Early psoriatic arthritis: Short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)

Annals of the Rheumatic Diseases

Volumn 73, Issue 2, 2014, Pages 407-413

  Theander, Elke ^a   Husmark, Tomas ^b   Alenius, Gerd Marie ^c   Larsson, Per T ^d   Teleman, Annika ^e   Geijer, Mats ^a   Lindqvist, Ulla R C ^f  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b FALUN HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Spenshult Rheumatology Hospital   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DELAYED DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; MALE; OUTCOME ASSESSMENT; PHARMACEUTICAL CARE; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SEX DIFFERENCE; SWEDEN; SYMPTOM ASSESSMENT; WELLBEING;

EID: 84891739710     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201972     Document Type: Article

References (20)

1. Scarpa R, Ayala F, Caporaso N, et al. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006;33:210-12. (Pubitemid 43209292)
2. Kane D, Stafford L, Bresnihan B, et al. A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis-'DIP or not DIP revisited'. Rheumatology (Oxford) 2003;42:1469-76. (Pubitemid 37508920)
3. Gladman DD, Farewell VT, Wong K, et al. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998;41:1103-10. (Pubitemid 28265412)
4. Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
5. Gladman DD, Thavaneswaran A, Chandran V, et al. Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? Ann Rheum Dis 2011;70:2152-4.
6. Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, et al. A polyarticular onset predicts erosive and deforming disease in psoriatic arthritis. Ann Rheum Dis 2003;62:68-70. (Pubitemid 36005799)
7. Ali Y, Tom BD, Schentag CT, et al. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007;56:2708-14. (Pubitemid 47237289)
8. Lindqvist UR, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register-2-year followup: a comparison with early rheumatoid arthritis. J Rheumatol 2008;35:668-73. (Pubitemid 351500064)
9. Svensson B, Holmstrom G, Lindqvist U. Development and early experiences of a Swedish psoriatic arthritis register. Scand J Rheumatol 2002;31:221-5. (Pubitemid 34971879)
10. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73. (Pubitemid 44205029)
11. Chandran V, Schentag CT, Gladman DD. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007;57:1560-3. (Pubitemid 350308858)
12. Fitzgerald O, Helliwell P, Mease P, et al. Application of composite disease activity scores in psoriatic arthritis to the PRESTA data set. Ann Rheum Dis 2012;71:358-62.
13. Schoels M, Aletaha D, Funovits J, et al. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010;69:1441-7.
14. Mumtaz A, Gallagher P, Kirby B, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 2011;70:272-7.
15. Lukas C, Landewe R, Sieper J, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 2009;68:18-24.
16. Coates LC, Fransen J, Helliwell PS. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53.
17. Gladman DD, Brubacher B, Buskila D, et al. Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clin Invest Med 1992;15:371-5.
18. Queiro R, Sarasqueta C, Torre JC, et al. Comparative analysis of psoriatic spondyloarthropathy between men and women. Rheumatol Int 2001;21:66-8. (Pubitemid 33036134)
19. Eder L, Thavaneswaran A, Chandran V, et al. Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis. Ann Rheum Dis 2013;72:578-82.
20. Saevarsdottir S, Wallin H, Seddighzadeh M, et al. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 2011;70:469-75.